Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Therapeutics

 

Photo: e-Magine Art

 

The emergence of antibiotic resistance has severely reduced the effectiveness of all antibiotics clinically used today. At the same time very few fundamentally new antibiotics have been developed in the past 20 years. Thus, we are rapidly running out of treatment options for CPE infections. Development of new lead compounds is a difficult, high-risk problem that requires a multidisciplinary approach.

CARe aim to, in collaboration with health care and industry, identify new treatment options and to develop new antibiotic substances.

Page Manager: Webbredaktionen|Last update: 6/30/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?